Recombinase polymerase amplification as a promising tool in hepatitis C virus diagnosis

World Journal of Hepatology

Volumn 6, Issue 12, 2014, Pages 916-922

  Zaghloul, Hosam ^a   El Shahat, Mahmoud ^b  

^a MANSOURA UNIVERSITY   (Egypt)

^b Mansoura University   (Egypt)

Author keywords

Hepatitis C virus; Nucleic acid testing; Point of care; Polymerase chain reaction; Recombinase polymerase amplification

Indexed keywords

EID: 84919983264     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v6.i12.916     Document Type: Short Survey

References (51)

1. Purcell R. The hepatitis C virus: overview. Hepatology 1997; 26 11S-14S [PMID: 9305657 DOI: 10.1002/hep.510260702].
2. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 1998; 282: 103-107 [PMID: 9756471 DOI: 10.1126/science.282.5386.103].
3. Joyce MA, Tyrrell DL. The cell biology of hepatitis C virus. Microbes Infect 2010; 12: 263-271 [PMID: 20080204 DOI: 101016/j.micinf.2009.12.012].
4. Averhoff FM, Glass N, Holtzman D. Global burden of hepatitis C: considerations for healthcare providers in the United States. Clin Infect Dis 2012; 55 Suppl 1: S10-S15 [PMID: 22715208 DOI: 10.1093/cid/cis361].
5. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13: 2436-2441 [PMID: 17552026 DOI: 103748/wjg.v13.i17.2436].
6. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57: 1333-1342 [PMID: 23172780 DOI: 10.1002/hep.26141].
7. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000; 20: 1-16 [PMID: 10895428 DOI: 10.1055/s-2000-9506].
8. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci 2006; 3: 41-46 [PMID: 16614741 DOI: 107150/ijms.3.41].
9. Yen T, Keeffe EB, Ahmed A. The epidemiology of hepatitis C virus infection. J Clin Gastroenterol 2003; 36: 47-53 [PMID: 12488709 DOI: 10.1097/00004836-200301000-00015].
10. Martins T, Narciso-Schiavon JL, Schiavon Lde L. [Epidemiology of hepatitis C virus infection]. Rev Assoc Med Bras 2011; 57 107-112 [PMID: 21390467 DOI: 10.1016/S2255-4823(11)70024-8].
11. Hepatitis C-global prevalence (update). Wkly Epidemiol Rec 1999; 74: 425-427 [PMID: 10645164].
12. Alter MJ. Prevention of spread of hepatitis C. Hepatology 2002; 36 S93-S98 [PMID: 12407581 DOI: 10.1002/hep.1840360712].
13. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998; 47: 1-39 [PMID: 9790221].
14. Puro V, Petrosillo N, Ippolito G. Risk of hepatitis C seroconversion after occupational exposures in health care workers. Italian Study Group on Occupational Risk of HIV and Other Bloodborne Infections. Am J Infect Control 1995; 23: 273-277 [PMID: 8585637 DOI: 10.1016/0196-6553(95)90056-X].
15. Roberts EA, Yeung L. Maternal-infant transmission of hepatitis C virus infection. Hepatology 2002; 36: S106-S113 [PMID: 12407583 DOI: 10.1002/hep.1840360714].
16. Terrault NA. Sexual activity as a risk factor for hepatitis C. Hepatology 2002; 36: S99-105 [PMID: 12407582 DOI: 10.1053/jhep.2002.36797].
17. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, Sallam I. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000; 355: 887-891 [PMID: 10752705 DOI: 10.1016/S0140-6736(99)06527-7].
18. NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens State Sci Statements 2002; 19: 1-46 [PMID: 14768714].
19. Schafer DF, Sorrell MF. Conquering hepatitis C, step by step. N Engl J Med 2000; 343: 1723-1724 [PMID: 11106723 DOI: 10.1056/NEJM200012073432309].
20. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52 [PMID: 11439948 DOI: 10.1056/NEJM200107053450107].
21. Pawlotsky JM, Lonjon I, Hezode C, Raynard B, Darthuy F, Remire J, Soussy CJ, Dhumeaux D. What strategy should be used for diagnosis of hepatitis C virus infection in clinical laboratories? Hepatology 1998; 27: 1700-1702 [PMID: 9620345 DOI: 10.1002/hep.510270632].
22. Zhu WF, Lei SY, Li LJ. Hepatitis C virus infection and biological false-positive syphilis test: a single-center experience. Hepatobiliary Pancreat Dis Int 2011; 10: 399-402 [PMID: 21813389 DOI: 10.1016/S1499-3872(11)60067-2].
23. Senevirathna D, Amuduwage S, Weerasingam S, Jayasinghe S, Fernandopulle N. Hepatitis C virus in healthy blood donors in Sri Lanka. Asian J Transfus Sci 2011; 5: 23-25 [PMID: 21572710 DOI: 10.4103/0973-6247.75976].
24. Thio CL, Nolt KR, Astemborski J, Vlahov D, Nelson KE, Thomas DL. Screening for hepatitis C virus in human immunodeficiency virus-infected individuals. J Clin Microbiol 2000; 38 575-577 [PMID: 10655348].
25. Kalantar-Zadeh K, Miller LG, Daar ES. Diagnostic discordance for hepatitis C virus infection in hemodialysis patients. Am J Kidney Dis 2005; 46: 290-300 [PMID: 16112048 DOI: 10.1053/j.ajkd.2005.05.006].
26. Leon R, de Medina M, Schiff ER. Diagnostic tools in the evaluation of patients with viral hepatitis undergoing liver transplantation. Liver Transpl Surg 1998; 4: 94-103 [PMID: 9457974 DOI: 10.1002/lt.500040114].
27. Young KK, Archer JJ, Yokosuka O, Omata M, Resnick RM. Detection of hepatitis C virus RNA by a combined reverse transcription PCR assay: comparison with nested amplification and antibody testing. J Clin Microbiol 1995; 33: 654-657 [PMID: 7751372].
28. Busch MP, Kleinman SH, Jackson B, Stramer SL, Hewlett I, Preston S. Committee report. Nucleic acid amplification testing of blood donors for transfusion-transmitted infectious diseases: Report of the Interorganizational Task Force on Nucleic Acid Amplification Testing of Blood Donors. Transfusion 2000; 40: 143-159 [PMID: 10685998 DOI: 10.1046/j.1537-2995.2000.40020143.x].
29. Hendricks DA, Friesenhahn M, Tanimoto L, Goergen B, Dodge D, Comanor L. Multicenter evaluation of the VERSANT HCV RNA qualitative assay for detection of hepatitis C virus RNA. J Clin Microbiol 2003; 41: 651-656 [PMID: 12574262 DOI: 10.1128/JCM.41.2.651-656.2003].
30. Komurian-Pradel F, Paranhos-Baccalà G, Sodoyer M, Chevallier P, Mandrand B, Lotteau V, André P. Quantitation of HCV RNA using real-time PCR and fluorimetry. J Virol Methods 2001; 95: 111-119 [PMID: 11377718 DOI: 10.1016/S0166-0934(01)00300-7].
31. Kim J, Easley CJ. Isothermal DNA amplification in bioanalysis: strategies and applications. Bioanalysis 2011; 3: 227-239 [PMID: 21250850 DOI: 10.4155/bio.10.172].
32. Craw P, Balachandran W. Isothermal nucleic acid amplification technologies for point-of-care diagnostics: a critical review. Lab Chip 2012; 12: 2469-2486 [PMID: 22592150 DOI: 101039/c2lc40100b].
33. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, Hase T. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 2000; 28: E63 [PMID: 10871386 DOI: 10.1093/nar/28.12.e63].
34. Walker GT, Fraiser MS, Schram JL, Little MC, Nadeau JG, Malinowski DP. Strand displacement amplification-an isothermal, in vitro DNA amplification technique. Nucleic Acids Res 1992; 20: 1691-1696 [PMID: 1579461 DOI: 10.1093/nar/20.7.1691].
35. Lizardi PM, Huang X, Zhu Z, Bray-Ward P, Thomas DC, Ward DC. Mutation detection and single-molecule counting using isothermal rolling-circle amplification. Nat Genet 1998; 19 225-232 [PMID: 9662393 DOI: 10.1038/898].
36. Vincent M, Xu Y, Kong H. Helicase-dependent isothermal DNA amplification. EMBO Rep 2004; 5: 795-800 [PMID: 15247927 DOI: 10.1038/sj.embor.7400200].
37. Piepenburg O, Williams CH, Stemple DL, Armes NA. DNA detection using recombination proteins. PLoS Biol 2006; 4: e204 [PMID: 16756388].
38. Euler M, Wang Y, Nentwich O, Piepenburg O, Hufert FT, Weidmann M. Recombinase polymerase amplification assay for rapid detection of Rift Valley fever virus. J Clin Virol 2012; 54 308-312 [PMID: 22683006 DOI: 10.1016/j.jcv.2012.05.006].
39. Euler M, Wang Y, Otto P, Tomaso H, Escudero R, Anda P, Hufert FT, Weidmann M. Recombinase polymerase amplification assay for rapid detection of Francisella tularensis. J Clin Microbiol 2012; 50: 2234-2238 [PMID: 22518861 DOI: 101128/JCM.06504-11].
40. Abd El Wahed A, Patel P, Heidenreich D, Hufert FT, Weidmann M. Reverse transcription recombinase polymerase amplification assay for the detection of middle East respiratory syndrome coronavirus. PLoS Curr 2013; 5: [PMID: 24459611 DOI: 10.1371/currents.outbreaks.62df1c7c75ffc96cd59034531e2e8364].
41. Euler M, Wang Y, Heidenreich D, Patel P, Strohmeier O, Hakenberg S, Niedrig M, Hufert FT, Weidmann M. Development of a panel of recombinase polymerase amplification assays for detection of biothreat agents. J Clin Microbiol 2013; 51 1110-1117 [PMID: 23345286 DOI: 10.1128/JCM.02704-12].
42. Ahmed A, van der Linden H, Hartskeerl RA. Development of a recombinase polymerase amplification assay for the detection of pathogenic Leptospira. Int J Environ Res Public Health 2014; 11: 4953-4964 [PMID: 24814943 DOI: 10.3390/ijerph110504953].
43. Kersting S, Rausch V, Bier FF, von Nickisch-Rosenegk M. Multiplex isothermal solid-phase recombinase polymerase amplification for the specific and fast DNA-based detection of three bacterial pathogens. Mikrochim Acta 2014; 181: 1715-1723 [PMID: 25253912 DOI: 10.1007/s00604-014-1198-5].
44. Kersting S, Rausch V, Bier FF, von Nickisch-Rosenegk M. Rapid detection of Plasmodium falciparum with isothermal recombinase polymerase amplification and lateral flow analysis. Malar J 2014; 13: 99 [PMID: 24629133 DOI: 101186/1475-2875-13-99].
45. Paul N, Shum J, Le T. Hot start PCR. Methods Mol Biol 2010; 630: 301-318 [PMID: 20301005 DOI: 10.1007/978-1-60761-629-0_19].
46. Shen F, Davydova EK, Du W, Kreutz JE, Piepenburg O, Ismagilov RF. Digital isothermal quantification of nucleic acids via simultaneous chemical initiation of recombinase polymerase amplification reactions on SlipChip. Anal Chem 2011; 83 3533-3540 [PMID: 21476587 DOI: 10.1021/ac200247e].
47. Sharma N, Hoshika S, Hutter D, Bradley KM, Benner SA. Recombinase-based isothermal amplification of nucleic acids with self-avoiding molecular recognition systems (SAMRS). Chembiochem 2014; 15: 2268-2274 [PMID: 25209570 DOI: 101002/cbic.201402250].
48. Kutyavin IV, Rhinehart RL, Lukhtanov EA, Gorn VV, Meyer RB, Gamper HB. Oligonucleotides containing 2-aminoadenine and 2-thiothymine act as selectively binding complementary agents. Biochemistry 1996; 35: 11170-11176 [PMID: 8780521 DOI: 10.1021/bi960626v].
49. Gamper HB, Arar K, Gewirtz A, Hou YM. Unrestricted hybridization of oligonucleotides to structure-free DNA. Biochemistry 2006; 45: 6978-6986 [PMID: 16734433 DOI: 10.1021/bi0600392].
50. Hoshika S, Chen F, Leal NA, Benner SA. Artificial genetic systems: self-avoiding DNA in PCR and multiplexed PCR. Angew Chem Int Ed Engl 2010; 49: 5554-5557 [PMID: 20586087 DOI: 10.1002/anie.201001977].
51. Karami A, Gill P, Motamedi MH, Saghafinia M. A review of the current isothermal amplification techniques: Applications, advantages and disadvantages. J Global Infect Dis 2011;3: 293-302 [DOI: 10.4103/0974-777X.83538].